⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3319139 | 0.95 | — | — | |
| SCHEMBL17311837 | 0.87 | — | — | |
| SCHEMBL5359 | 0.84 | — | — | |
| SCHEMBL8432414 | 0.80 | TRIM24 (0.38) | — | |
| SCHEMBL8081626 | 0.80 | TRIM24 (0.38) | — | |
| SCHEMBL258196 | 0.80 | — | — | |
| SCHEMBL5682760 | 0.80 | TRIM24 (0.31) | — | |
| SCHEMBL5400 | 0.80 | — | — | |
| SCHEMBL21114263 | 0.80 | TRIM24 (0.38) | — | |
| SCHEMBL7732749 | 0.80 | TRIM24 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7737 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024138201-A2 | SELECTIVE BET INHIBITORS AND USES THEREOF | Tay Therapeutics Limited (GB) | 2024-06-27 | — | — | WO | claimed |
| WO-2024126648-A1 | SULFOXIMINES AS INHIBITORS OF NaV1.8 | Grünenthal GmbH (DE) | 2024-06-20 | — | — | WO | claimed |
| EP-4385979-A1 | MULTICYCLIC INHIBITORS OF NAV1.8 | Grünenthal GmbH (DE) | 2024-06-19 | — | — | EP | claimed |
| EP-4385980-A1 | INDAZOLES AS INHIBITORS OF NAV1.8 | Grünenthal GmbH (DE) | 2024-06-19 | — | — | EP | claimed |
| EP-4385984-A1 | PYRIDINE-N-OXIDES AS INHIBITORS OF NAV1.8 | Grünenthal GmbH (DE) | 2024-06-19 | — | — | EP | claimed |
| CN-113874353-B | Microbiocidal derivatives | 先正达农作物保护股份公司 | 2024-06-14 | — | — | CN | claimed |
| WO-2024118887-A1 | N-PHENYL-PYRAZOLO[1,5-A]PYRIDINE-3-CARBOXAMIDE DERIVATIVES AS WILD TYPE C-KIT KINASE INHIBITORS FOR THE TREATMENT OF URTICARIA | BLUEPRINT MEDICINES CORPORATION (US) | 2024-06-06 | — | — | WO | claimed |
| WO-2024104244-A1 | OXAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 四川科伦博泰生物医药股份有限公司 | 2024-05-23 | — | — | WO | claimed |
| US-20240140915-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS | VIVIDION THERAPEUTICS, INC. | 2024-05-02 | — | — | US | claimed |
| US-20240131040-A1 | COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS | Natural Extraction Systems, LLC (US) | 2024-04-25 | — | — | US | claimed |
| US-4754059-A | ANTISECRETORY AGENT WITH REDUCED DIARRHEA SIDE EFFECT | G. D. SEARLE & CO. (US) | 1988-06-28 | — | — | US | claimed |
| US-4713477-A | ANTISECRETORY AGENTS | G. D. SEARLE & CO. (US) | 1987-12-15 | — | — | US | claimed |
| EP-0239357-A2 | Process for preparing monosodium phosphoenolpyruvate and use of the same as visceral function improver | UBE INDUSTRIES, LTD. (JP) | 1987-09-30 | — | — | EP | claimed |
| US-4678781-A | BACTERICIDAL ANTIBIOTICS | ICI PHARMA (FR) | 1987-07-07 | — | — | US | claimed |
| EP-0187456-A1 | Cephalosporin derivatives | ICI PHARMA (FR) | 1986-07-16 | — | — | EP | claimed |
| EP-0182633-A2 | Cephalosporin derivatives | ICI PHARMA (FR) | 1986-05-28 | — | — | EP | claimed |
| EP-0164944-A1 | Cephalosporin derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-12-18 | — | — | EP | claimed |
| EP-0127992-A2 | Cephalosporin derivatives | ICI PHARMA (FR) | 1984-12-12 | — | — | EP | claimed |
| EP-0024960-B1 | SUBSTITUTED HETEROCYCLIC PHENOXY AMINES, THEIR PREPARATION METHOD AND THEIR USE AS LOCAL ANAESTHETICS | SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE-DE-FRANCE (FR) | 1984-12-12 | — | — | EP | claimed |
| US-4231925-A | TYROSINE, METHIONINE, SERINE | AMERICAN HOME PRODUCTS CORPORATION (US) | 1980-11-04 | — | — | US | claimed |